KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

West Pharmaceutical Services (WST) Payables (2016 - 2026)

West Pharmaceutical Services has reported Payables over the past 18 years, most recently at $252.3 million for Q1 2026.

  • Quarterly Payables rose 10.46% to $252.3 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $252.3 million through Mar 2026, up 10.46% year-over-year, with the annual reading at $253.7 million for FY2025, 6.02% up from the prior year.
  • Payables was $252.3 million for Q1 2026 at West Pharmaceutical Services, down from $253.7 million in the prior quarter.
  • Over five years, Payables peaked at $255.8 million in Q3 2025 and troughed at $188.9 million in Q3 2022.
  • The 5-year median for Payables is $233.8 million (2023), against an average of $231.2 million.
  • Peak annual rise in Payables hit 21.49% in 2022, while the deepest fall reached 9.05% in 2022.
  • Tracing WST's Payables over 5 years: stood at $215.4 million in 2022, then increased by 12.53% to $242.4 million in 2023, then dropped by 1.28% to $239.3 million in 2024, then rose by 6.02% to $253.7 million in 2025, then decreased by 0.55% to $252.3 million in 2026.
  • According to Business Quant data, Payables over the past three periods came in at $252.3 million, $253.7 million, and $255.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.